financetom
Business
financetom
/
Business
/
Update: Market Chatter: Citigroup-Led Banks Approach Private Credit Amid Noosa Yoghurt Loan Hurdles
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Market Chatter: Citigroup-Led Banks Approach Private Credit Amid Noosa Yoghurt Loan Hurdles
Feb 7, 2025 9:37 AM

12:03 PM EST, 02/07/2025 (MT Newswires) -- (Updates with Citigroup's ( C ) reply to a request for comment in the last paragraph.)

A group of banks led by Citigroup ( C ) is approaching private credit firms after struggling to sell a $575 million leveraged loan package for Lakeview Farms' acquisition of Noosa Yoghurt, Bloomberg reported Friday, citing sources with knowledge of the matter.

The financing includes a riskier second-lien loan, which, along with concerns over Lakeview's high debt levels, has deterred traditional collateralized loan obligation managers, according to the media outlet.

Investors who reviewed the deal late last year were reportedly wary of Lakeview's leverage and the potential for fluctuating consumer demand for products like salsa and dips amid high interest rates.

Lakeview Farms, a portfolio company of CapVest Partners, agreed in November to acquire Noosa from Campbell's Company (CPB), according to Bloomberg.

The banks reportedly launched a $500 million first-lien loan sale at the end of last month, with investor commitments due Monday. The loan is being offered at 5% to 5.25% over the benchmark rate and at 95 cents on the dollar.

The debt will be used not only to fund the Noosa acquisition but also to refinance Lakeview Farms' existing obligations, Bloomberg reported, citing Moody's Ratings.

Lakeview's leverage is expected to reach between 7 and 7.5 times earnings for the current 12-month period, potentially decreasing to 5.5 to 6 times if earnings grow in the next 12 to 18 months, according to Moody's Ratings.

CapVest and Citigroup ( C ) declined to comment, while Lakeview Farms and Noosa Yoghurt did not immediately respond to requests for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 81.93, Change: -0.40, Percent Change: -0.49

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Joby Aviation Insider Sold Shares Worth $383,547, According to a Recent SEC Filing
Joby Aviation Insider Sold Shares Worth $383,547, According to a Recent SEC Filing
Jul 15, 2025
05:28 PM EDT, 07/15/2025 (MT Newswires) -- Kate DeHoff, General Counsel and Corporate Secretary, on July 12, 2025, sold 29,085 shares in Joby Aviation ( JOBY ) for $383,547. Following the Form 4 filing with the SEC, Dehoff has control over a total of 202,276 common shares of the company, with 202,276 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1819848/000181984825000467/xslF345X05/wk-form4_1752614666.xml ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Repare Signs Licensing Deal With Debiopharm for Lunresertib
Repare Signs Licensing Deal With Debiopharm for Lunresertib
Jul 15, 2025
05:28 PM EDT, 07/15/2025 (MT Newswires) -- Repare Therapeutics ( RPTX ) said late Tuesday it has signed a global licensing agreement with Debiopharm International for its cancer drug candidate lunresertib. Repare said it will get a $10 million upfront payment, and could earn up to $257 million in potential milestones from Debiopharm, a privately-owned, Swiss-based biopharmaceutical company. This agreement...
US SEC ends Cognizant bribery case that the Justice Department also abandoned
US SEC ends Cognizant bribery case that the Justice Department also abandoned
Jul 15, 2025
July 15 (Reuters) - The U.S. Securities and Exchange Commission ended a civil bribery case against two former Cognizant Technology Solutions executives, after President Donald Trump decided to stop enforcing a key anti-corruption law. In a filing in the Newark, New Jersey federal court, the SEC said it dismissed claims against Gordon Coburn and Steven Schwartz in the exercise of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved